(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ANTICORPOS ANTI-GPC3 E MÉTODOS DE USO

ArquivadaInvention PatentPCT · CN2022088432

Application data

Number

112023021557

Type

Invention Patent

Filing

04/22/2022

Publication

12/19/2023

PCT

CN2022088432

Progress at the INPI

  1. Filing04/22/22
  2. Publication12/19/23
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 04/22/2022 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 07/22/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

SHANGHAI HENLIUS BIOTECH, INC.

CN

See this company's full portfolio

Inventors

H. I. (pessoa física)

CN

H. K. (pessoa física)

CN

W. J. (pessoa física)

CN

W. X. (pessoa física)

CN

Technical data

IPC Classification

Priority claims

CN

PCT/CN2021/089233 · 04/23/2021

Abstract

ANTICORPOS ANTI-GPC3 E MÉTODOS DE USO. São fornecidos anticorpos e derivados de anticorpos que se ligam a GPC3 e métodos para usar os mesmos. O anticorpo ou derivado de anticorpo compreende um anticorpo de domínio único que se liga a GPC3.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

07/22/2025

RPI 2846

Arquivamento - Art. 33 da LPI

#11.1

05/06/2025

RPI 2835

Notificação de entrada na fase nacional - PCT

#1.3

12/19/2023

RPI 2763

Alteração de dados cadastrais

#1.1

10/24/2023

RPI 2755

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.